Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Using a special stent to help reverse gastric bypass surgery

Official title: Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass: a Proof of Concent Study

Run by University Hospital, Ghent · NCT05640947 · Data updated 2026-11-12

This study is testing whether a special stent can help people who need their gastric bypass reversed feel better and improve their nutrition without needing surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations2 sites (Bruges and 1 other locations)
StatusRecruiting
StartedJanuary 30, 2023
Main results expectedOctober 2027
Study endsFebruary 2028
Registry record updatedOctober 8, 2025
Trial IDNCT05640947 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients requiring parenteral nutritional support, those with symptomatic dumping syndrome, patients with refractory marginal ulcers, and individuals with severe liver fibrosis post-bypass.

Probably not a fit

Patients with uncorrectable coagulopathy or significant portal hypertension may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the effectiveness of an endoscopically placed lumen-apposing metal stent as a non-surgical alternative for patients requiring reversal of their gastric bypass. The study focuses on patients with specific conditions such as hypoglycemia, gastric outlet obstruction, and severe liver fibrosis. Participants will receive the Hot AXIOS™ Stent and Electrocautery-Enhanced Delivery System to assess the stent's ability to alleviate symptoms and improve nutritional status. The study is open-label, meaning both researchers and participants will know the treatment being administered.

Why it matters

Potential benefit: If successful, this approach could provide a less invasive option for patients needing gastric bypass reversal, potentially improving their quality of life.

How similar studies have gone: While this approach is innovative, similar studies exploring endoscopic interventions for gastric bypass complications have shown promise, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Group 1) patients needing any kind of parenteral nutritional support (eg. hypo- albuminemia, hypovitaminoses, mineral deficiencies,...) that can not be corrected by dietary intervention/oral supplementation
* Group 2) patients with persistent invalidating symptomatic dumping syndrome despite optimal dietary intervention (typical complaints are headache, sweating, trembling, weakness and feeling hungry).
* Group 3) patients with a refractory marginal ulcers with stenosis of the gastrojejunostomy leading to feading difficulties.
* Group 4) patients with F3 or F4 liver fibrosis and a tendency to decompensation after bypass surgery, as demonstrated by an increase in serum bilirubin/INR and/or lowering of serum albumin.

Exclusion Criteria:

1. Uncorrectable coagulopathy
2. Presence of significant portal hypertension as demonstrated by 2.1) the presence of esophageal and/or gastric varices AND/OR 2.2) a hepatic venous pressure gradient (if measured) equal to or more than 10mm Hg AND/OR 2.3) the combination of

   1. a platelet count \<150000/µl AND
   2. liver stiffness measured by elastometry equal to or more than 20 kPa (Baveno guidelines).
3. Pregnant women, breastfeeding women or women that can not assure adequate anticonception for the duration of the study (based on anamnesis).
4. Karnofsky index less than 60
5. Vulnerable patients

Where it's running

  • AZ Sint-Jan Brugge
    Bruges, Belgium
    Recruiting
  • University Hospital, Ghent
    Ghent, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.